| Eliza Seros, OD | |
|
4114 W Maple Rd, Bloomfield Hills, MI 48301-3000 | |
| (248) 539-4800 | |
| Not Available |
| Full Name | Eliza Seros |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 3 Years |
| Location | 4114 W Maple Rd, Bloomfield Hills, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184295982 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Birmingham Vision Care | 5193734192 | 4 |
News Archive
Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.
A selection of health policy stories from California, Mississippi, Oregon, Texas, Florida, Kansas and Colorado.
A growing area of medicine looks at how cellular binding observed in nature - where molecules like viruses or proteins bind to specific receptors on a cell - can be mimicked to aid drug delivery.
Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve prostate cancer survival rates.
Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.
› Verified 3 days ago
| Provider Name | Birmingham Vision Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619038312 PECOS PAC ID: 5193734192 Enrollment ID: O20060420000007 |
News Archive
Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.
A selection of health policy stories from California, Mississippi, Oregon, Texas, Florida, Kansas and Colorado.
A growing area of medicine looks at how cellular binding observed in nature - where molecules like viruses or proteins bind to specific receptors on a cell - can be mimicked to aid drug delivery.
Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve prostate cancer survival rates.
Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eliza Seros, OD 4114 W Maple Rd, Bloomfield Hills, MI 48301-3000 Ph: () - | Eliza Seros, OD 4114 W Maple Rd, Bloomfield Hills, MI 48301-3000 Ph: (248) 539-4800 |
News Archive
Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.
A selection of health policy stories from California, Mississippi, Oregon, Texas, Florida, Kansas and Colorado.
A growing area of medicine looks at how cellular binding observed in nature - where molecules like viruses or proteins bind to specific receptors on a cell - can be mimicked to aid drug delivery.
Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve prostate cancer survival rates.
Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.
› Verified 3 days ago
Mrs. Maryjo Ference, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Paul Charles Feinberg, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Debra Lynn Feinberg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Michael S Weishaus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6523 Telegraph Rd, Bloomfield Hills, MI 48301 Phone: 248-593-9955 Fax: 248-593-9966 | |
Vision Specialists Of Michigan Optometrist Medicare: Medicare Enrolled Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-7362 | |
Dr. Kevin Semma, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3683 W Maple Rd, Bloomfield Hills, MI 48301 Phone: 248-246-4466 |